Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2016. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1766623015 | Nadolol+bendroflumethiazide (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1778222012 | Nadolol+bendroflumethiazide | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2477023017 | Bendroflumethiazide + nadolol | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 2693810013 | Bendroflumethiazide + Nadolol | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3288226012 | Bendroflumethiazide + nadolol (product) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3503291017 | Product containing bendroflumethiazide and nadolol (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3503292012 | Bendroflumethiazide and nadolol | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3503293019 | Product containing bendroflumethiazide and nadolol | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3666808012 | Bendroflumethiazide and nadolol product | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3713419013 | Bendroflumethiazide- and nadolol-containing product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 59565101000001111 | Nadolol +Bendroflumethiazide | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| 95385901000001118 | Nadolol + Bendroflumethiazide | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet | Is a | False | Product containing bendroflumethiazide and nadolol | Inferred relationship | Existential restriction modifier | |
| Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet | Is a | False | Product containing bendroflumethiazide and nadolol | Inferred relationship | Existential restriction modifier | |
| Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form) | Is a | True | Product containing bendroflumethiazide and nadolol | Inferred relationship | Existential restriction modifier | |
| Nadolol + Bendroflumethiazide | Is a | True | Product containing bendroflumethiazide and nadolol | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets